Development of Gutless Adenoviral Vectors Encoding Anti Angiogenic Proteins for Therapy of Prostate Cancer

doi 10.21236/ada438181
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

The Role of Adenoviral Vectors in Genetic Prodrug Activation Therapy in Prostate Cancer

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2000English

Enhanced Peptide of Prostate Cancer Using Targeted Adenoviral Vectors

2005English

Mesothelin-Mediated Targeting of Adenoviral Vectors for Ovarian Cancer Gene Therapy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2004English

Evaluation of CD46 Re-Targeted Adenoviral Vectors for Clinical Ovarian Cancer Intraperitoneal Therapy

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2016English

Development of HIV Vectors for Anti-Hiv Gene Therapy.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Interleukin-Encoding Adenoviral Vectors as Genetic Adjuvant for Vaccination Against Retroviral Infection

PLoS ONE
Multidisciplinary
2013English

Baculoviruses as Vectors for Gene Therapy Against Human Prostate Cancer

Journal of Biomedicine and Biotechnology
2003English

Anti‐angiogenic Therapies for Gastric Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Anti-Angiogenic Therapy for Cancer: Current Progress, Unresolved Questions and Future Directions

Angiogenesis
Cancer ResearchClinical BiochemistryPhysiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy